{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:54:28Z","timestamp":1777420468302,"version":"3.51.4"},"reference-count":21,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,4,23]],"date-time":"2017-04-23T00:00:00Z","timestamp":1492905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,4,23]],"date-time":"2017-04-23T00:00:00Z","timestamp":1492905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/ane.12765","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T02:17:23Z","timestamp":1493000243000},"page":"401-406","source":"Crossref","is-referenced-by-count":6,"title":["Gait instability in valproate-treated patients: Call to measure ammonia levels"],"prefix":"10.1155","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5150-1364","authenticated-orcid":false,"given":"S.","family":"Kipervasser","sequence":"first","affiliation":[{"name":"EEG and Epilepsy Unit; Department of Neurology; Tel-Aviv Sourasky Medical Center; Tel-Aviv Israel"},{"name":"Sackler School of Medicine; Tel-Aviv University; Tel-Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Elger","sequence":"additional","affiliation":[{"name":"Department of Epileptology; University of Bonn; Bonn Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Korczyn","sequence":"additional","affiliation":[{"name":"Sackler School of Medicine; Tel-Aviv University; Tel-Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D.","family":"Nass","sequence":"additional","affiliation":[{"name":"Department of Epileptology; University of Bonn; Bonn Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Quesada","sequence":"additional","affiliation":[{"name":"Department of Epileptology; University of Bonn; Bonn Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Y.","family":"Neufeld","sequence":"additional","affiliation":[{"name":"EEG and Epilepsy Unit; Department of Neurology; Tel-Aviv Sourasky Medical Center; Tel-Aviv Israel"},{"name":"Sackler School of Medicine; Tel-Aviv University; Tel-Aviv Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,23]]},"reference":[{"key":"10.1111\/ane.12765-BIB0001|ane12765-cit-0001","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35\u00a0years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1111\/ane.12765-BIB0002|ane12765-cit-0002","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.yebeh.2007.02.013","article-title":"Different clinical manifestations of hyperammonemic encephalopathy","volume":"10","author":"Gomceli","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12765-BIB0003|ane12765-cit-0003","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3122\/jabfm.2007.05.070062","article-title":"Valproate-associated hyperammonemic encephalopathy","volume":"20","author":"Wadzinski","year":"2007","journal-title":"J Am Board Fam Med"},{"key":"10.1111\/ane.12765-BIB0004|ane12765-cit-0004","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1528-1157.2002.42201.x","article-title":"Valproate-induced encephalopathy: assessment with MRI imaging and HMR spectroscopy","volume":"43","author":"Ziyeh","year":"2002","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12765-BIB0005|ane12765-cit-0005","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10072-011-0852-5","article-title":"Unilateral basal ganglia involvement likely due to VPA induced hyperammonic encephalopathy","volume":"33","author":"Joardan","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1111\/ane.12765-BIB0006|ane12765-cit-0006","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reaction induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1111\/ane.12765-BIB0007|ane12765-cit-0007","first-page":"1039","article-title":"Valproate-induced hyperammonemic encephalopathy: a brief review","volume":"28","author":"Lewis","year":"2012","journal-title":"Neurology"},{"key":"10.1111\/ane.12765-BIB0008|ane12765-cit-0008","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1248\/bpb.35.971","article-title":"Correlation between plasma ammonia level and serum trough concentration of free valproic acid in patients with epilepsy","volume":"35","author":"Itoh","year":"2012","journal-title":"Biol Pharm Bull"},{"key":"10.1111\/ane.12765-BIB0009|ane12765-cit-0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000000066","article-title":"Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy","volume":"93","author":"Tseng","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/ane.12765-BIB0010|ane12765-cit-0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0019-5545.42400","article-title":"Valproate monotherapy induced-delirium due to hyperammonemia: a report of three adult cases with different types of presentation","volume":"50","author":"Pradeep","year":"2008","journal-title":"Indian Psychiatry"},{"key":"10.1111\/ane.12765-BIB0011|ane12765-cit-0011","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.seizure.2011.02.009","article-title":"Reversible dementia and gait disturbance after prolonged use of valproic acid","volume":"20","author":"Evans","year":"2011","journal-title":"Seizure"},{"key":"10.1111\/ane.12765-BIB0012|ane12765-cit-0012","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-016-0341-8","article-title":"Valproate-Associated Parkinsonism: A Critical Review of the Literature","volume":"30","author":"Brugger","journal-title":"CNS Drugs"},{"key":"10.1111\/ane.12765-BIB0013|ane12765-cit-0013","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.63.8.1202","article-title":"Hippocampal involvement in valproate-induced acute hyperammonemic encephalopathy","volume":"63","author":"Soares-Fernandes","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12765-BIB0014|ane12765-cit-0014","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000345226","article-title":"Fatal hyperammonemic brain injury from valproic acid exposure","volume":"4","author":"Bega","year":"2012","journal-title":"Case Rep Neurol"},{"key":"10.1111\/ane.12765-BIB0015|ane12765-cit-0015","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1378\/chest.06-2940","article-title":"Hyperammonemia in the ICU","volume":"132","author":"Clay","year":"2007","journal-title":"Chest"},{"key":"10.1111\/ane.12765-BIB0016|ane12765-cit-0016","first-page":"1","article-title":"A reversible cause of coma in epilepsy","volume":"13","author":"Kesav","year":"2012","journal-title":"BMJ Case, Report"},{"key":"10.1111\/ane.12765-BIB0017|ane12765-cit-0017","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pediatrneurol.2012.12.039","article-title":"Lacosamide-induced valproic acid toxicity","volume":"48","author":"Jones","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1111\/ane.12765-BIB0018|ane12765-cit-0018","doi-asserted-by":"crossref","unstructured":"Thompson PD Frontal lobe ataxia. Chapter 44. Handbook of Clinical Neurology 2012 103 619 622","DOI":"10.1016\/B978-0-444-51892-7.00044-9"},{"key":"10.1111\/ane.12765-BIB0019|ane12765-cit-0019","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eplepsyres.2012.04.001","article-title":"Risk factors for hyperammonemia associated with valproic acid therapy in adult epileptic patients","volume":"101","author":"Yamamoto","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12765-BIB0020|ane12765-cit-0020","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/WNF.0b013e3181ac3615","article-title":"Valproate induced hyperammonemic encephalopathy and normal liver functions. Possible synergism with Topiramate","volume":"32","author":"Deutsch","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/ane.12765-BIB0021|ane12765-cit-0021","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/chi.0b013e31802ed8b2","article-title":"Case report: valproic Acid and risperdone treatment leading to development of hyperammonemia and mania","volume":"46","author":"Carlson","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12765","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12765\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:50:20Z","timestamp":1671540620000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,23]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12765","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,23]]}}}